BSE filing, NSE: VENMAX. Summary written from the filing by ALFA Finder's alert engine.
Venmax Drugs & Pharmaceuticals Ltd: key numbers
- Share price
- ₹14.00
- Market cap
- ₹12.30 Cr
- Revenue (annual)
- ₹8.02 Cr
- Net profit (annual)
- ₹0.25 Cr
- P/E (TTM)
- 43.9×Sector 37.9×
- Promoter holding
- 10.46%+0.00% QoQ
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Venmax Drugs & Pharmaceuticals Ltd
All →Venmax Drugs & Pharmaceuticals Acquisition
Venmax Drugs' shareholders met on 24 October 2026 under an NCLT order to approve an amalgamation with Hatri Pharma. Voting results await the scrutinizer's report.
Venmax Drugs & Pharmaceuticals Other Announcement
The company filed its quarterly shareholding pattern under Regulation 31(1)(b) of the SEBI LODR Regulations for the quarter ended September 30, 2026.
Venmax Drugs & Pharmaceuticals Annual General Meeting
Venmax Drugs and Pharmaceuticals held its 37th Annual General Meeting on September 26, 2026. Shareholders considered the financial statements and various directorship appointments.
Venmax Drugs & Pharmaceuticals Acquisition
Venmax Drugs and Pharmaceuticals Limited announced an NCLT-convened meeting of equity shareholders on October 24, 2026, to consider the proposed merger with Hatri Pharma Private Limited.
Venmax Drugs & Pharmaceuticals Acquisition
NCLT Hyderabad directed Venmax to convene a shareholder meeting on 24 Oct 2026 for the amalgamation of Hatri Pharma into Venmax. The order also dispensed with meetings of Hatri Pharma's shareholders and creditors.
Venmax Drugs & Pharmaceuticals Annual Report
Venmax Drugs and Pharmaceuticals Limited has submitted its Annual Report for the Financial Year 2025-26, including the Notice for its 37th Annual General Meeting.
Other board meeting date announcements
All →AA Plus Tradelink Board Meeting Date
AA Plus Tradelink will hold a board meeting on 14 November 2026 to consider unaudited half-year results ended 30 September 2026. This is a future-dated Regulation 29 board meeting notice.
Western Overseas Study Abroad Board Meeting Date
Western Overseas Study Abroad will meet on 13 November 2026 to approve half-year unaudited results. Trading window stays closed until results are declared.
Elevate Campuses Board Meeting Date
Elevate Campuses Limited gave prior intimation of a board meeting on 12 November 2026. The board will consider unaudited consolidated and standalone results for the quarter and half year ended September 2026.
DJS Stock & Shares Board Meeting Date
DJS Stock and Shares will meet on 13 November 2026 to consider September 2026 quarter and half-year results. Advance notice only; results not yet approved.
Cochin Minerals & Rutile Board Meeting Date
Cochin Minerals & Rutile will hold a board meeting on 12 November 2026 to consider unaudited results for the quarter and half year ended 30 September 2026. This is a future-dated board meeting notice.
Shreevatsaa Finance & Leasing Board Meeting Date
Shree Vatsaa will hold a board meeting on 14 November 2026 to consider unaudited quarterly and half-yearly results. Trading window stays closed until 48 hours after declaration.